BIORESTORATIVE THERAPI
1.6100
08-November-24 12:52:49
15 minutes delayed
Stocks
+0.0500
+3.21%
Today's range
1.5500 - 1.6500
ISIN
N/A
Source
NASDAQ
-
BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100
13 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioRestorative Therapies to Participate at the 35th Annual ROTH MKM Conference on March 12 -14, 2023
07 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
08 Feb 2023 09:00:01 By Nasdaq GlobeNewswire
-
06 Dec 2022 07:00:00 By Nasdaq GlobeNewswire
-
29 Nov 2022 11:20:00 By Nasdaq GlobeNewswire
-
16 Nov 2022 08:56:00 By Nasdaq GlobeNewswire
-
BioRestorative Therapies CEO Lance Alstodt to be Interviewed on Famela and Friends Talk Radio Show
20 Oct 2022 09:30:00 By Nasdaq GlobeNewswire
-
28 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference
27 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
07 Sep 2022 07:00:02 By Nasdaq GlobeNewswire
-
30 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
22 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
13 Jun 2022 07:00:00 By Nasdaq GlobeNewswire
-
29 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
18 Apr 2022 08:00:00 By Nasdaq GlobeNewswire
-
BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification
04 Apr 2022 08:00:02 By Nasdaq GlobeNewswire
-
10 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program
16 Feb 2022 08:30:00 By Nasdaq GlobeNewswire